Science Explorer Interactive view Map
Company · Waltham · United States

Minerva Biotechnologies (United States)

minervabio.comROR OpenAlex
Research works
30
▲ 208% vs 2013–17
Citations
382
12.6 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
20%
world 28%

Not ranked overall: Minerva Biotechnologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Minerva Biotechnologies (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Cancer Immunotherapy, Glycosylation, CAR T Cells, Chimeric Antigen Receptor, Monoclonal Antibodies and Tumor Targeting.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 28 words, with their numbers
  1. Immunotherapy10▲ 51×3 topics
  2. Tumor Regression10▲ 375×2 topics
  3. Cancer Immunotherapy7▲ 161×2 topics
  4. Glycosylation6▲ 97×2 topics
  5. CAR T Cells6▲ 482×1 topic
  6. Chimeric Antigen Receptor6▲ 482×1 topic
  7. Monoclonal Antibodies5▲ 109×2 topics
  8. Tumor Targeting5▲ 118×2 topics
  9. Fc Receptors4▲ 148×1 topic
  10. Therapeutic Antibodies4▲ 115×1 topic
  11. Arginine Deprivation4▲ 269×1 topic
  12. Bacterial Therapy4▲ 269×1 topic
  13. Epithelial-Mesenchymal Transition3▲ 114×2 topics
  14. Cancer2▲ 5.9×4 topics
  15. Cancer Therapy2▲ 12×5 topics
  16. Metastasis Suppressors2▲ 1712×1 topic
  17. NDRG Family2▲ 1712×1 topic
  18. Immune System2▲ 21×2 topics
  19. Therapeutics2▲ 49×2 topics
  20. Glycans2▲ 81×1 topic
  21. Mucins2▲ 81×1 topic
  22. Biomedical Applications2▲ 5.8×6 topics
  23. Drug Delivery2▲ 12×5 topics
  24. Tumor Microenvironment2▲ 16×3 topics
  25. Nanoparticles1▲ 3.3×2 topics
  26. Nanocarriers1▲ 88×1 topic
  27. Surface Engineering1▲ 34×1 topic
  28. Angiogenesis1▲ 8.2×2 topics

Which research topics does Minerva Biotechnologies (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Mechanisms of cancer metastasis, Cancer Research and Treatments and Cancer, Hypoxia, and Metabolism.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksMechanisms of cancer metastasis: 2 fractional worksCancer Research and Treatments: 1 fractional worksCancer, Hypoxia, and Metabolism: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksImmunotherapy and Immune…0Immunotherapy and Immune Responses: 0 fractional worksCongenital heart defects research: 0 fractional worksBiochemical and Molecular Research: 0 fractional worksDNA and Biological Computing: 0 fractional worksDevelopmental Biology and Gene Regulation: 0 fractional works
OncologyMolecular BiologyBiotechnologyCancer Research2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Mechanisms of cancer metastasis Molecular Biology 2 works
  3. 3 Cancer Research and Treatments Biotechnology 1 works
  4. 4 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 Immunotherapy and Immune Responses Immunology 0 works
  7. 7 Congenital heart defects research Molecular Biology 0 works
  8. 8 Biochemical and Molecular Research Molecular Biology 0 works
  9. 9 DNA and Biological Computing Molecular Biology 0 works
  10. 10 Developmental Biology and Gene Regulation Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available19.7%not open80.3%

World: 28% of research is openly available.

with international co-authors5.5%domestic only94.5%

World: 19% is written across borders.

How has Minerva Biotechnologies (United States)'s research output changed?

Output in 2018–2022 was 208% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Waltham

All research institutions in Waltham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.